ImmunityBio (IBRX) Goodwill (2024 - 2026)
ImmunityBio (IBRX) reported Goodwill of $910000.0 for Q1 2026, little changed year-over-year from $910000.0 in Q1 2025, and little changed quarter-over-quarter from $910000.0 in Q4 2025.
ImmunityBio (IBRX) Goodwill (2024 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 3 years of Goodwill data on file, last reported at $910000.0 in Q1 2026.
- Goodwill for Q1 2026 came in at $910000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $910000.0 (changed 0.0% YoY), and the FY2025 annual result was $910000.0, changed 0.0% from the prior year.
- Goodwill held at $910000.0 in Q1 2026 per IBRX's latest filing, from $910000.0 in the prior quarter.
- Over five years, Goodwill peaked at $910000.0 in Q4 2024 and troughed at $900000.0 in Q3 2024.
- A 3-year average of $908571.4 and a median of $910000.0 in 2024 frame the typical range for Goodwill.
- On a YoY basis, Goodwill climbed as much as 1.11% in 2025 and fell as far as 0.0% in 2025.
- A 3-year view of Goodwill shows it stood at $910000.0 in 2024, then changed by 0.0% to $910000.0 in 2025, then changed by 0.0% to $910000.0 in 2026.
- Business Quant data shows IBRX's Goodwill at $910000.0 in Q1 2026, $910000.0 in Q4 2025, and $910000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 910,000.00 |
| Dec 31, 2025 | 910,000.00 |
| Sep 30, 2025 | 910,000.00 |
| Jun 30, 2025 | 910,000.00 |
| Mar 31, 2025 | 910,000.00 |
| Dec 31, 2024 | 910,000.00 |
| Sep 30, 2024 | 900,000.00 |